Lipid formulations for patients requiring parenteral nutrition a review of clinical and cost-effectiveness and guidelines
A previous CADTH report, published in 2009, entitled "n-3 Lipids for Patients on Total Parenteral Nutrition: A Review of the Clinical and Cost-Effectiveness" summarized the results from 10 randomized controlled trials, four observational studies, and one economic evaluation. The evidence i...
| Main Authors: | , , |
|---|---|
| Corporate Author: | |
| Format: | eBook |
| Language: | English |
| Published: |
Ottawa (ON)
Canadian Agency for Drugs and Technologies in Health
2017, July 19, 2017
|
| Edition: | Version: 1.0 |
| Series: | CADTH rapid response report: summary with critical appraisal
|
| Subjects: | |
| Online Access: | |
| Collection: | National Center for Biotechnology Information - Collection details see MPG.ReNa |
| Summary: | A previous CADTH report, published in 2009, entitled "n-3 Lipids for Patients on Total Parenteral Nutrition: A Review of the Clinical and Cost-Effectiveness" summarized the results from 10 randomized controlled trials, four observational studies, and one economic evaluation. The evidence indicated fish oil to be safe and well-tolerated with some randomized controlled trials showing reduced hospital stay and/or anti-inflammatory effects with the administration of n-3 fatty acids. The economic evaluation did not support the cost-effectiveness of fish oil for parenteral nutrition (PN). The current report aims to review the clinical effectiveness and cost-effectiveness of various lipid emulsions for PN in all patient populations requiring PN. This report also aims to review evidence-based guidelines pertaining to the use of various lipid intravenous lipid emulsions (ILEs) in patients requiring PN. |
|---|---|
| Physical Description: | 1 PDF file (66 pages) illustrations |